The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...
Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...
The rapifleX MALDI PharmaPulse (MPP) accelerates label-free hit finding in drug discovery: rapifleX MPP combines the unambiguousness of mass spectrometry with the required speed to comb through large ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
Bruker announced its new MALDI PharmaPulse 2.0 solution (MPP 2.0), which enhances the automation capabilities of the rapifleX MALDI-TOF mass spectrometer, with its proprietary scanning 10 kHz ...
Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...
SAN FRANCISCO, June 20, 2019 /PRNewswire/ -- At the ASM Microbe Conference 2019 (www.asm.org), Bruker launches the new MALDI Biotyper sirius system for all previously FDA-cleared, and for all research ...
ATLANTA, May 31, 2019 /PRNewswire/ -- At the 67 th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass spectrometry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results